A retrospective observational cohort study to determine survival outcomes and treatments patterns in patients with relapsed or refractory multiple myeloma in France in real-world settings
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Daratumumab (Primary) ; Ixazomib (Primary) ; Lenalidomide (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Annals of Hematology